Howard B. Schiller

Overview

Howard B. Schiller received an average of $9.3M in compensation at Valeant Pharmaceuticals International from 2011 to 2015.

Source: SEC filings on April 29, 2016, April 9, 2015, and April 22, 2014.

Related executives

We found 25 more executives who work or worked at Valeant Pharmaceuticals International.

Joseph Papa

Valeant Pharmaceuticals International

Chief Executive Officer

Paul Herendeen

Valeant Pharmaceuticals International

Chief Financial Officer

Thomas Appio

Valeant Pharmaceuticals International

President & Co, Head, Bausch + Lomb/International

Christina Ackermann

Valeant Pharmaceuticals International

General Counsel

Joseph Gordon

Valeant Pharmaceuticals International

President & Co, Head, Bausch + Lomb/International

William Humphries

Valeant Pharmaceuticals International

Group Chairman

J Pearson

Valeant Pharmaceuticals International

Chief Executive Officer

Robert Rosiello

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like